Regencell Bioscience Holdings Limited operates a Traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
Regencell Bioscience Dividend Announcement
• Regencell Bioscience announced a quarterly dividend of $0.22 per ordinary share which will be made payable on 2018-02-26. Ex dividend date: 2018-02-15
• Regencell Bioscience's trailing twelve-month (TTM) dividend yield is -%
Regencell Bioscience Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2018-02-15 | $0.22 | quarterly | 2018-02-26 |
2017-12-01 | $0.22 | quarterly | 2017-12-15 |
2017-08-31 | $0.22 | quarterly | 2017-09-15 |
2017-06-01 | $0.22 | quarterly | 2017-06-15 |
2017-03-01 | $0.22 | quarterly | 2017-03-15 |
2016-12-01 | $0.22 | quarterly | 2016-12-15 |
2016-08-31 | $0.22 | quarterly | 2016-09-15 |
2016-06-02 | $0.22 | quarterly | 2016-06-16 |
2016-03-02 | $0.22 | quarterly | 2016-03-15 |
2015-12-02 | $0.22 | quarterly | 2015-12-15 |
2015-09-02 | $0.22 | quarterly | 2015-09-15 |
2015-05-29 | $0.22 | quarterly | 2015-06-12 |
2015-02-27 | $0.22 | quarterly | 2015-03-13 |
2014-12-02 | $0.22 | quarterly | 2014-12-15 |
2014-09-03 | $0.22 | quarterly | 2014-09-15 |
2014-05-30 | $0.22 | quarterly | 2014-06-13 |
2014-02-28 | $0.22 | quarterly | 2014-03-14 |
2013-12-02 | $0.21 | quarterly | 2013-12-13 |
2013-09-05 | $0.21 | quarterly | 2013-09-17 |
2013-05-31 | $0.21 | quarterly | 2013-06-14 |
2013-03-01 | $0.21 | quarterly | 2013-03-15 |
2012-12-03 | $0.21 | quarterly | 2012-12-14 |
2012-09-06 | $0.21 | quarterly | 2012-09-18 |
2012-06-01 | $0.21 | quarterly | 2012-06-15 |
2012-03-01 | $0.21 | quarterly | 2012-03-15 |
2011-12-05 | $0.21 | quarterly | 2011-12-16 |
2011-09-07 | $0.21 | quarterly | 2011-09-19 |
2011-06-01 | $0.21 | quarterly | 2011-06-15 |
2011-03-01 | $0.21 | quarterly | 2011-03-15 |
2010-12-06 | $0.18 | quarterly | 2010-12-17 |
2010-09-07 | $0.18 | quarterly | 2010-09-17 |
2010-06-01 | $0.18 | quarterly | 2010-06-15 |
2010-03-02 | $0.18 | quarterly | 2010-03-16 |
2009-12-07 | $0.18 | quarterly | 2009-12-17 |
2009-09-08 | $0.18 | quarterly | 2009-09-18 |
2009-06-02 | $0.18 | quarterly | 2009-06-16 |
Regencell Bioscience Dividend per year
Regencell Bioscience Dividend growth
Regencell Bioscience Dividend Yield
Regencell Bioscience current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Regencell Bioscience stock? Use our calculator to estimate your expected dividend yield:
Regencell Bioscience Financial Ratios
Regencell Bioscience Dividend FAQ
Other factors to consider when evaluating Regencell Bioscience as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy Regencell Bioscience stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: Regencell Bioscience's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, Regencell Bioscience publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, Regencell Bioscience distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from Regencell Bioscience are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: Regencell Bioscience sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, Regencell Bioscience distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: Regencell Bioscience declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of Regencell Bioscience's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review Regencell Bioscience's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.